Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial

BACKGROUND: Pancreatic cancer is the fourth largest cause of cancer death in the United States and Europe with over 100,000 deaths per year in Europe alone. The overall 5-year survival ranges from 2–7 % and has hardly improved over the last two decades. Approximately 15 % of all patients have resect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Trials
Main Authors: Versteijne, Eva, van Eijck, Casper H. J., Punt, Cornelis J. A., Suker, Mustafa, Zwinderman, Aeilko H., Dohmen, Miriam A. C., Groothuis, Karin B. C., Busch, Oliver R. C., Besselink, Marc G. H., de Hingh, Ignace H. J. T., ten Tije, Albert J., Patijn, Gijs A., Bonsing, Bert A., de Vos-Geelen, Judith, Klaase, Joost M., Festen, Sebastiaan, Boerma, Djamila, Erdmann, Joris I., Molenaar, I. Quintus., van der Harst, Erwin, van der Kolk, Marion B., Rasch, Coen R. N., van Tienhoven, Geertjan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4784417/
https://ncbi.nlm.nih.gov/pubmed/26955809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1262-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados